SAMHSA/HHS will publish the following Notices in the 15 May 2015 Federal Register. The Notices are available in pdf format today.
Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid that allow federal agencies to collect and test oral fluid specimens in their workplace drug testing programs. https://federalregister.gov/a/2015-11523
Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine (URMG) that revise standards and technical requirements of the current Guidelines. https://federalregister.gov/a/2015-11524
Comments on the OFMG and URMG must be submitted within 60 days after publication. Instructions for submitting comments are included in the Notices.
Oral Fluid Mandatory Guidelines. The proposed OFMG establish standards and technical requirements for oral fluid collection devices, initial oral fluid drug test analytes and methods, confirmatory oral fluid drug test analytes and methods, processes for review by a Medical Review Officer (MRO), and requirements for federal agency actions.
Urine Mandatory Guidelines. The proposed revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Programs will revise the initial and confirmatory drug test analytes and methods for urine testing, revise the cutoff for reporting a specimen as adulterated based on low pH, revise the requalification requirements for individuals serving as MROs and, where appropriate, include references to the use of an alternate specimen in federal workplace drug testing programs.
Testing for new drugs: In addition to expanding testing for both oral fluid and urine, the URMG and OFMG will include urine and oral testing procedures for four Schedule II prescription medications: hydrocodone, hydromorphone, oxycodone, and oxymorphone not currently included in the Mandatory Guidelines.